European Journal Of Cancer

European Journal Of Cancer

欧洲癌症杂志

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《European Journal Of Cancer》是由Elsevier Ltd出版社于1965年创办的英文国际期刊(ISSN: 0959-8049,E-ISSN: 1879-0852),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为医学-肿瘤学。作为SCI、SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA开放获取模式(OA占比0.2544...%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比90.98%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在377篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

European Journal Of Cancer审稿周期约为约1.0个月。该刊近年未被列入国际预警名单,年发文量约377篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 377 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
2区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
2区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
2区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
2区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 45 / 333

86.6

学科:ONCOLOGY SCIE Q1 39 / 333

88.44

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 45 / 328

86.4

学科:ONCOLOGY SCIE Q1 38 / 328

88.57

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 38 / 322

88.4

学科:ONCOLOGY SCIE Q1 34 / 322

89.6

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:10.9 SJR:2.692 SNIP:2.164
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q1 47 / 428

89%

大类:Medicine 小类:Cancer Research Q1 42 / 233

82%

期刊发文

  • Translating ctDNA into cutaneous melanoma care: An international expert surve

    Author: Geidel, Glenn; Fekade, Nathan; Raabe, Katharina; Smit, Daniel J.; Adam, Laura; Heidrich, Isabel; Rünger, Alessandra; Kött, Julian; Zell, Tim; Amaral, Teresa; Ascierto, Paolo A.; Corrie, Pippa; Dummer, Reinhard; Eggermont, Alexander; Guo, Jun; Hassel, Jessica C.; Jalving, Mathilde; Johnson, Douglas B.; Kandolf, Lidija; Kirkwood, John M.; Lebbé, Celeste; Lee, Rebecca; Long, Georgina V; Lorigan, Paul; Malvehy, Josep; Mangana, Joanna; Mohr, Peter; Patel, Sapna P.; Rizos, Helen; Robert, Caroline; Schadendorf, Dirk; Sondak, Vernon K.; Svane, Inge Marie; Wainstein, Alberto; Zager, Jonathan S.; Pantel, Klaus; Hauschild, Axel; Gebhardt, Christoffer

    Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 239, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116676

  • Implementing a molecular prescreening strategy for tumors without public NGS access in a cancer center network: Results from the PREICO projec

    Author: Sabat, Paula; Ajenjo-Bauza, Maria; Hierro, Cinta; Ruffinelli, Jose Carlos; Gil-Martin, Marta; Ochoa-de-Olza, Maria; Bergamino, Milana; Calvo, Mariona; Soto-Castillo, Juan Jose; Fina, Claudia; Llop, Sandra; Stradella, Agostina; Oliva, Marc; Notario, Lucia; Carcereny, Enric; Teixidor-Vila, Eduard; Domenech, Marta; Jove, Maria; Villanueva, Rafael; Alay, Ania; Azuara, Daniel; Gonzalez-Acosta, Maribel; Otero-Torres, Sara; Gausachs, Mireia; Varela, Mar; Villatoro, Sergi; Solanes, Ares; Teule, Alexandre; Cuadra, Carmen; Moreno, Victor; Nadal, Ernest; Cordero, David; Lazaro, Conxi; Martin-Liberal, Juan

    Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 239, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116728

  • Population impact of PSA screening: Evidence beyond clinical trial

    Author: Vaccarella, Salvatore; Li, Mengmeng; Auvinen, Anssi; Dal, Luigino

    Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 238, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116615

  • Clinical utility of large language models in metastatic prostate cancer: A multicenter expert validation for decision suppor

    Author: Chen, Yinsong; He, Kangwen; Qu, Weinuo; Ma, Luping; Su, Xing; Liu, Xinqi; Kang, Zhen; Li, Feng; Yan, Junrong; Wang, Zhibo; Li, Jing; Li, Zhen

    Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 238, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116667

  • Stereotactic body radiotherapy versus hepatic resection for recurrent small hepatocellular carcinoma: A post-hoc analysis with propensity score adjustment from two randomized trial

    Author: Fu, Yizhen; Liu, Shiliang; Chen, Jinbin; Zhang, Li; Wang, Juncheng; Pan, Yangxun; Xu, Li; Fang, Aiping; Chen, Minshan; Zhang, Yaojun; Xi, Mian

    Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 238, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116675

  • MuTriM: A multiscale deep learning model integrating longitudinal radiomics and pathomic features for predicting recurrence and adjuvant radiation benefit in breast cance

    Author: Wang, Xiangxue; Chen, Liya; Sun, Jingwen; Khalighi, Sirvan; Dam, Tanmoy; Maurya, Himanshu; Pathak, Tilak; Lu, Cheng; Gandhi, Shipra; Badve, Sunil; Zhao, Shen; Yang, Wentao; Xu, Jun; Madabhushi, Anant; Song, Bolin

    Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 238, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116679

  • Potential induction of protective anti-tumor immune response in cancer patients by oncolytic viruses containing the GGTA1 gen

    Author: Galili, Uri; Zhao, Yongxiang

    Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 236, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116251

  • Preclinical characterization and first-in-human, phase I trial of the novel ALK inhibitor dirozalkib in advanced non-small cell lung cance

    Author: Ai, Xinghao; Guo, Renhua; Zhang, Liang; Fang, Jian; Zhang, Yiping; Chen, Jianhua; Zhao, Jun; Ye, Feng; Wang, Shumei; Shi, Meiqi; Zhang, Xinwei; Zhang, Fang; Li, Jiakui; Wang, Li; Guo, Xuejie; Xu, Lingmei; Duan, Xianghui; Hu, Yan; Lu, Shun

    Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 235, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116221